Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Saturday's Bonus Article Oklo: The Bottom Is In, and the Upside Potential Is NuclearSubmitted by Thomas Hughes. Article Published: 3/19/2026. 
Key Points - Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
- Analysts responded favorably, affirming the forecast for a 50% stock price increase.
- Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
Oklo Inc. (NYSE: OKLO) faces headwinds, including a lack of revenue and profits, but that doesn't seem to matter to investors. The company's fiscal year 2025 (FY2025) progress report and updates show it is on track to meet long-term goals and market expectations. The market response — including analyst updates released after the report — says it all: near-term revenue isn't the focus given the perceived long-term opportunity. Analysts Focus on Oklo's Long-Term Opportunity MarketBeat tracked about half a dozen analyst revisions within the first 12 hours after the release. Those included one reduced price target, offset by a larger number of affirmed ratings and targets, with no downgrades. The takeaway is that the activity aligns with the broader trend: increasing coverage, a steady Moderate Buy rating, a 58% Buy-side bias, and an upward drift in price targets. Price targets matter here because consensus forecasts imply more than 50% upside from mid‑March lows. Although analysts expressed concern about the 2025 results, they remain focused on the long-term opportunity and on progress with Nuclear Regulatory Commission licensing. The company received its first license, awarded to its subsidiary Atomic Alchemy, which produces isotopes. The license allows the receiving, possession, storage, processing, repackaging, and distribution of up to two curies of radium-226 — roughly two grams. Two grams isn't much, and radium-226 on its own is not particularly valuable. It was once used in medicines but is now a nuisance to handle and remediate. However, it is increasingly in demand as a precursor for actinium, one of the most expensive elements used in specialized cancer treatments that can cost roughly $20,000 per dose. The implication for investors is that Oklo's diversification strategy has been validated and a revenue stream has been opened. It may take a few quarters for meaningful revenue to appear, but it could arrive well before commercialization of its core nuclear reactor technologies. Institutional and Short-Selling Data Reveal the Bottom is In for Oklo Stock Institutional and short-selling data point to a bottom for Oklo stock. While short interest remains elevated — near 15% as of early March — it is down from its peak (which coincided with Oklo's October 2025 highs) and is likely to fall further in future reports. Institutional activity has moved the other direction: buying accelerated after Oklo's Q2 2025 plunge and reached record levels in early 2026. This group now owns about 85% of the stock, provides solid support, and appears to be accumulating at roughly $3 bought for every $1 sold. If those trends continue, the float available to trade should shrink dramatically over the coming months, supporting higher prices. A catalytic news event could also trigger a short squeeze. Dilutive Headwinds Cease in 2026 Shareholder dilution was a headwind in 2025 but is easing in 2026. The company's share count rose about 50% year over year, yet the balance sheet remains well capitalized. FY2026 plans suggest sufficient capital for roughly two years at the current burn rate, providing a window for secondary revenue streams, such as the isotope business, to mature. The trade-off: profitability isn't expected until 2030, so additional capital may be required later. The technical setup looks constructive. OKLO is trading well below its highs and appears oversold relative to March levels. The MACD has diverged and turned bullish, and the stochastic oscillator has followed, signaling a strong buy at current prices. The question is whether the market will follow through on those signals; it may take time for the momentum to build. Even with a promising outlook, the lack of current revenue and profits remains a significant burden for the stock. The biggest risk is execution and delay. The market is pricing in robust future growth — effectively valuing the stock at more than 100 times its initial-year earnings — and may react poorly to setbacks. In that scenario, Oklo could experience significant volatility whether the rebound begins now or later. | 
